Tesofensine/Metoprolol Tartrate

特索芬辛/酒石酸美托洛尔

Report date: 2024/07/22 20:00:45

Base Information

Drug NameTesofensine/Metoprolol Tartrate
Drug Alias NameMetoprolol/Tesofensine酒石酸美托洛尔/特索芬辛Tesofensine/metoprololMetoprolol Tartrate/TesofensineTesomet
ClassificationSmall molecules
Mechanisms of ActionBeta adrenergic receptors antagonistsSerotonin transporter inhibitorsDopamine transporter antagonists +[4] 
TargetsNorepinephrine transporterBeta adrenergic receptorsDopamine transporter +[4] 
Therapy Area/IndicationsHypothalamic ObesityDiabetes Mellitus, Type 2Prader-Willi Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesHungary +[4] 
CombinationsYes Metoprolol TartrateTesofensine
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSaniona A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSaniona A/S
Active IndicationsN/A
Inactive IndicationsHypothalamic ObesityDiabetes Mellitus, Type 2Prader-Willi Syndrome

Other Information

ATC CodeN/A
Related LinksN/A